Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine: Comparison of Prophylaxis and Therapy

Lignende værker

• Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25(+) Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
  af: Sutmuller, Roger P.M., et al.
  Udgivet: (2001)
• CD4 T Cells and Their Role in Antitumor Immune Responses
  af: Toes, René E.M., et al.
  Udgivet: (1999)
• Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
  af: Xia Liu, et al.
  Udgivet: (2022-10-01)
• Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein
  af: Medema, Jan Paul, et al.
  Udgivet: (1999)
• Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
  af: Peggs, Karl S., et al.
  Udgivet: (2009)